Filing Details

Accession Number:
0000895345-23-000524
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-25 21:28:31
Reporting Period:
2023-08-23
Accepted Time:
2023-08-25 21:28:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808865 Iteos Therapeutics Inc. ITOS () 1231
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1015747 Joseph Lewis C/O Cay House
Ep Taylor Drive N7776, Lyford Cay
New Providence Bahamas
No No No No
1465836 Boxer Asset Management Inc. C/O Cay House
Ep Taylor Drive
New Providence C5 N7776
No No No No
1465837 Boxer Capital, Llc 12860 El Camino Real
Suite 300
San Diego CA 92130
No No No No
1465914 I. Aaron Davis 12860 El Camino Real, Suite 300
San Diego CA 92130
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-23 34,846 $14.19 2,119,212 No 4 S Direct
Common Stock Disposition 2023-08-23 95,516 $15.63 2,023,696 No 4 S Direct
Common Stock Disposition 2023-08-23 219,638 $16.87 1,804,058 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.80 to $14.59, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.05 to $15.85, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.50 to $17.04, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.